Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Thyroid disorders during interferon alpha therapy in 625 patients with chronic hepatitis C: a prospective cohort study.

Annales d'endocrinologie - 1 Sept 2006

Kabbaj N, Guedira M M, El Atmani H, El Alaoui M, Mohammadi M, Benabed K, Lachkar H, Benaïssa A

Abstract excerpt

AIM: to report the prevalence, risk factors, management and long-term outcome of thyroid disorders caused by INFalpha in patients with chronic hepatitis C. PATIENTS AND METHODS: From January 1991 to December 2004, 625 patients with chronic hepatitis C underwent INFalpha therapy. TSH assay was normal and antithyroperoxidase antibodies (anti-TPO) was performed before onset antiviral treatment; then TSH was...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Autoantibodies

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Hepatitis C, Chronic

Share to Interferon-alpha

Share to Thyroid Diseases

Share to Thyroid Gland

Share to Thyrotropin

Share to Viral Load

Source

Identifiers

PMID: 17072240
DOI: 10.1016/s0003-4266(06)72609-9

Genes

TPO

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Thyroid disorders during interferon alpha therapy in 625 patients with chronic hepatitis C: a prospective cohort study.PMID 17072240Read ↗

Interferon alpha treatment and thyroid dysfunction.Semantic proximity Read ↗

Virus C genotype predisposes to primary hypothyroidism during interferon-α treatment for chronic hepatitis C.Semantic proximity Read ↗

The clinical and physiological spectrum of interferon-alpha induced thyroiditis: toward a new classification.Semantic proximity Read ↗

Phenotypes of interferon-α-induced thyroid dysfunction among patients treated for hepatitis C are associated with pretreatment serum TSH and female sex.Semantic proximity Read ↗

Thyroid gland dysfunctions during antiviral therapy of chronic hepatitis C.Semantic proximity Read ↗

Interferon induced thyroiditis.Semantic proximity Read ↗

Cases of interferon-alpha and interferon-beta-induced thyroiditis.Semantic proximity Read ↗

Environmental triggers of thyroiditis: hepatitis C and interferon-α.Semantic proximity Read ↗

High prevalence of HCV (GT4)-related TSH abnormality among 13402 Egyptian patients treated with direct acting antiviral therapy.Semantic proximity Read ↗

Immunopathogenesis of HCV-related endocrine manifestations in chronic hepatitis and mixed cryoglobulinemia.Semantic proximity Read ↗

HLA-A2 subtype in patients with interferon-alpha-induced autoimmune thyroid disorders in chronic hepatitis C.Semantic proximity Read ↗

Association between human leukocyte antigen (HLA) and interferon- induced thyroid diseases in four patients with HCV-related chronic hepatitis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.